Eden Research (LON:EDEN) Stock Price Down 13.2% – Here’s What Happened

Shares of Eden Research plc (LON:EDENGet Free Report) were down 13.2% on Tuesday . The company traded as low as GBX 2.26 ($0.03) and last traded at GBX 2.37 ($0.03). Approximately 1,775,147 shares changed hands during trading, an increase of 133% from the average daily volume of 762,776 shares. The stock had previously closed at GBX 2.73 ($0.04).

Eden Research Stock Down 1.9 %

The firm has a 50-day simple moving average of GBX 3.34 and a 200 day simple moving average of GBX 3.70. The stock has a market capitalization of £13.87 million, a P/E ratio of -9.11 and a beta of 0.92. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42.

Insiders Place Their Bets

In other news, insider Lykele van der Broek bought 256,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 6th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, with a total value of £10,240 ($13,296.97). Also, insider Sean M. Smith purchased 426,986 shares of the business’s stock in a transaction on Tuesday, April 1st. The stock was purchased at an average price of GBX 234 ($3.04) per share, for a total transaction of £999,147.24 ($1,297,425.32). Insiders have acquired 1,391,473 shares of company stock valued at $103,604,725 in the last ninety days. 14.02% of the stock is currently owned by insiders.

About Eden Research

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.

Recommended Stories

Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.